| 2. Classification and Diagnosis of Diabetes: | Diabetes Care | 2021 | 540 |
| 9. Pharmacologic Approaches to Glycemic Treatment: | Diabetes Care | 2021 | 388 |
| COVID-19 and diabetes mellitus: from pathophysiology to clinical management | Nature Reviews Endocrinology | 2021 | 293 |
| Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2021 | 267 |
| 6. Glycemic Targets: | Diabetes Care | 2021 | 231 |
| Green Synthesis of Metallic Nanoparticles and Their Prospective Biotechnological Applications: an Overview | Biological Trace Element Research | 2021 | 226 |
| IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 | Diabetes Research and Clinical Practice | 2021 | 211 |
| SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas | Nature Metabolism | 2021 | 176 |
| Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients | Andrology | 2021 | 158 |
| 10. Cardiovascular Disease and Risk Management: | Diabetes Care | 2021 | 153 |
| Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 | Journal of Endocrinological Investigation | 2021 | 144 |
| Global pandemics interconnected - obesity, impaired metabolic health and COVID-19 | Nature Reviews Endocrinology | 2021 | 140 |
| The Impact of COVID-19 Stay-At-Home Orders on Health Behaviors in Adults | Obesity | 2021 | 120 |
| Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study | Thyroid | 2021 | 115 |
| Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection | Journal of Clinical Endocrinology and Metabolism | 2021 | 114 |
| Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland | Lancet Diabetes and Endocrinology,the | 2021 | 112 |
| Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19) | Diabetes/Metabolism Research and Reviews | 2021 | 111 |
| Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study | Lancet Diabetes and Endocrinology,the | 2021 | 107 |
| Epidemiology and determinants of obesity in China | Lancet Diabetes and Endocrinology,the | 2021 | 106 |
| Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials | Lancet Diabetes and Endocrinology,the | 2021 | 98 |
| Long COVID: An overview | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2021 | 97 |
| 11. Microvascular Complications and Foot Care: | Diabetes Care | 2021 | 94 |
| COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes | Diabetes Care | 2021 | 93 |
| 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: | Diabetes Care | 2021 | 93 |
| Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial | Lancet Diabetes and Endocrinology,the | 2021 | 91 |
